Skip to content

Margaret Ross

11 papers in the library · 120 citations · publishing 2019-2026

Papers

Sort Most recent Most cited

Participants’ Music Experiences Associated With Psychedelic-Assisted Psychotherapy for Life-Threatening Illness: Interpretivist Research

Journal of Music Therapy 2026 Clare O’callaghan, Voula Kallianis, Margaret Ross

Limited evidence supports treatment for distress in life-threatening illness. Psychedelic-assisted psychotherapy (PAP) may help. Despite music's presence in PAP, sparse accounts of music-related experiences exist. Such research is needed to optimize music's presence within PAP. This qualitative analysis aimed to understand participants' music-related accounts of their PAP experiences within a...

DOI: 10.1093/jmt/thag015 (opens in new tab) Anxiety Psilocybin Thematic analysis Music therapy +11

Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill

General Hospital Psychiatry December 10, 2025 Justin Dwyer, Robert B. Johnston, Clare O'Callaghan et al. 3 citations

This qualitative study of how successful Psychedelic Assisted Psychotherapy (PAP) transforms the way of life of terminally ill subjects provides new knowledge for researchers and clinicians contemplating its use. Using an interpretive phenomenological approach (IPA) and interviews with subjects before and after PAP from a recent randomised control trial, we find that participants with extreme...

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction September 20, 2025 Elizabeth Knock, Krista J. Siefried, Gillinder Bedi et al. 4 citations

Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study. Setting Outpatient public stimulant treatment program at St. Vincent's Hospital, Sydney,...

DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers.

Frontiers in Psychiatry August 15, 2025 Yvonne Bonomo, Amanda F. Norman, Lisa Collins et al. 1 citation

Introduction: Ayahuasca is a psychedelic compound of N, N, Dimethyltryptamine (DMT) and harmala alkaloids used for spiritual and medicinal applications in traditional settings. A range of potential psychotherapeutic mechanisms have been proposed for ayahuasca. These are thought to contribute to improvements in various psychiatric conditions including mood disorders and substance dependence....

DOI: 10.3389/fpsyt.2025.1545915 (opens in new tab) Full text (opens in new tab) Psychoactive Compounds DMT Harmala alkaloids Acacia Psychedelics +10

Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial

General Hospital Psychiatry August 12, 2025 Margaret Ross, Ravi Iyer, M.l. Williams et al. 13 citations

Psilocybin-assisted psychotherapy appears safe and may offer durable relief from depression and anxiety in individuals with a life-threatening illness.

DOI: 10.1016/j.genhosppsych.2025.08.001 (opens in new tab) Psilocybin Anxiety Randomized controlled trial Psychotherapist +3

Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement

BMJ Open April 1, 2025 Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum et al. 2 citations

Introduction Prolonged grief disorder (PGD) represents a substantial public health issue, especially in oncology settings where it affects up to 30% of bereaved carers. Current best-practice treatments are lengthy, and up to 50% of participants have persistent PGD. Building on encouraging recent research with psychedelic-assisted therapies, the Psilocybin-Assisted suppoRtive psychoTherapy IN...

DOI: 10.1136/bmjopen-2024-095992 (opens in new tab) Psilocybin Grief Thematic analysis Psychotherapist +2

Music as a collaborating actor: new insights into the nature and role of music in psychedelic-assisted psychotherapy.

Frontiers in Psychiatry 2025 Justin Dwyer, Robert B. Johnston, Clare O'Callaghan et al. 5 citations

Music has been identified as a central feature of psychedelic-assisted psychotherapy (PAP) and has hitherto been understood to amplify the psychedelic experience in a predictable way that has been codified into music recommendations and playlists. To re-evaluate the nature and role of music within the participant's world during psychedelic-assisted psychotherapy. Phenomenological analysis of...

Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead

Frontiers in Psychiatry November 4, 2021 M.l. Williams, Diana Korevaar, Renee Harvey et al. 23 citations

Research exploring the potential of psychedelic-assisted therapies to treat a range of mental illnesses is flourishing, after the problematic sociopolitical history of psychedelics led to the shutdown of clinical research for almost 40 years. Encouraged by positive results, clinicians and patients are now hopeful that further interruptions to research will be avoided, so that the early promise...

DOI: 10.3389/fpsyt.2021.737738 (opens in new tab) Flourishing Context archaeology Multidisciplinary approach Clinical trial +2

Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications

Journal of Music Therapy 2020 Clare O’callaghan, Daniel John Hubik, Justin Dwyer et al. 50 citations

Abstract Bonny Method of Guided Imagery and Music emerged following discontinuation of psychedelic therapy research in the early 1970s, but psychedelic therapy research has since revived. Music remains a vital component. This study examined participants’ experiences of music in psychedelic therapy research. A rapid review of qualitative and quantitative journal articles in four major databases...

Psilocybin-assisted therapy for depression: How do we advance the field?

Australian & New Zealand Journal of Psychiatry November 22, 2019 Sally Meikle, Paul Liknaitzky, Susan L. Rossell et al. 19 citations

In the quest for new treatment options for depression, attention is being paid to the potential role of psychedelic drugs. Psilocybin is of particular interest given its mechanism of action, its benefits in early trials and its relatively low side effects burden. This viewpoint outlines a number of key issues that remain to be elucidated about its potential use in the clinical environment,...

DOI: 10.1177/0004867419888575 (opens in new tab) Psilocybin Hallucinogen Psychotherapist Depression economics +4